DWM
DFTX

Diversify Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Diversify Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
11,000
+1,000
+10% +$17K ﹤0.01% 1055
2025
Q4 		$149K Hold
10,000
– – 0.01% 605
2025
Q3 		$123K Hold
10,000
– – 0.01% 526
2025
Q2 		$102K Hold
10,000
– – 0.01% 527
2025
Q1 		$63K Hold
10,000
– – ﹤0.01% 506
2024
Q4 		$69.3K Hold
10,000
– – 0.01% 508
2024
Q3 		$62.2K Hold
10,000
– – 0.01% 463
2024
Q2 		$74.7K Buy
+10,000
New +$87.5K 0.01% 425

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Diversify Wealth Management's DFTX Position: Q1 2026 in Review

Diversify Wealth Management increased its Definium Therapeutics (DFTX) stake by 10% in Q1 2026, buying an estimated $17K and bringing the position to 11,000 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Diversify Wealth Management first reported a position in DFTX in Q2 2024 and has held it in 8 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Diversify Wealth Management held 11,000 shares of Definium Therapeutics worth $225K as of Q1 2026.
  • Diversify Wealth Management bought 1,000 Definium Therapeutics shares in Q1 2026, an estimated $17K.
  • Definium Therapeutics made up ﹤0.01% of Diversify Wealth Management's portfolio in Q1 2026, its #1055 holding.
  • Diversify Wealth Management first reported a position in Definium Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Diversify Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.